-
-
-
-
-
-
-
Mersana Therapeutics Announces Second Quarter 2020 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Mersana (MRSN) PT Lowered to $12 at Baird
-
-
-
-
-
-
-
Baird Starts Mersana (MRSN) at Outperform
-
27,751 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

